● the archive
Every paper, appraised.
58 / 58 appraisals, search by topic, body region or verdict. Free shows the verdict & takeaway; members get every appraisal in full.
A 100k-lifter atlas shows flat bodyweight-multiplier strength targets get unrealistic as body mass rises, especially at elite levels and in women.
/100
A 'meta-analysis' built only from significant comparisons claims exergames match traditional activity for kids' movement skills, but no pooled effect size is reported.
/100
Adding strength training helped teen female players get stronger, pass better and score higher on a Stroop test, but their BDNF and IGF-1 levels didn't move, so skip the 'rewires the brain' pitch.
/100
Combined PAO plus arthroscopy gave 89% return-to-sport in this uncontrolled case series, in line with prior single-procedure data, not proof it's better.
/100
FIFA 11+ still edges out other hamstring prevention programs in this analysis, but the ranking is low-certainty and no trial has tested it head-to-head against Nordic exercise.
/100
We barely know why athletes eat ultra-processed foods, this review maps the gap rather than filling it.
/100
An untested opinion piece argues match-based load targets are too noisy to trust, but offers no data proving its proposed fix works.
/100
The 'no difference' between hamstring and quad tendon ACL grafts holds up statistically, but robust-null doesn't mean proven-equivalent.
/100
Two out of many strength-output associations hit p<0.05 in 42 AFL players, but without effect sizes or multiplicity correction, this isn't ready to guide readiness decisions.
/100
Screw vs suture bridge fixation for knee OCD heal at similar rates, but screws showed worse cartilage damage in this small, unblinded cohort.
/100
Young patients improve after cuff repair, but with no comparison group this case series can't tell you surgery beat the alternative.
/100
A progressive velocity decline in the final outings before shoulder surgery is a promising but unproven Statcast warning sign, not a screening tool yet.
/100
Deep learning 3D modeling maps sex-specific trochlear and growth plate development in teens, useful groundwork, but no effect sizes given and no surgical protocol yet.
/100
Nearly half of cuff repair patients have early stiffness, and those whose stiffness is pain-driven (not fear-driven) are the ones likely to stay stiff at 6 months.
/100
Velocity sensors and their 1RM predictions look reliable on paper, but missing error data and big heterogeneity mean treat the numbers as estimates, not a replacement for testing.
/100
BHD athletes did as well as non-dysplastic controls 10 years after hip arthroscopy with capsular plication, but there's no non-plication comparator to prove the plication mattered.
/100
Nicotine without tobacco looks less risky than smoking after cuff repair, but 'less bad than cigarettes' is not the same as safe.
/100
A scoping review finds hamstring rehab research is a mess of under-reported protocols and pain-based return-to-sport calls, not a source of new treatment guidance.
/100
A new MRI formula predicts QT graft diameter within 1mm in 90% of cases, but the screening cutoff for 'small grafts' has only 39% specificity.
/100
Biologically plausible case for exercise boosting checkpoint inhibitor efficacy, but it's all mice and cell culture so far, not patients.
/100
Your pre-tested deadlift 1RM overestimates true strength once fatigue sets in, velocity-based checks stay accurate, but this is a measurement study, not an outcomes trial.
/100
Athletes who pass RTS testing but still show force-plate asymmetry have nearly 1.5x the risk of tearing the other ACL, though this needs validation before changing clearance decisions.
/100
Post-ACLR PROM change scores can be off by 3-18 points because patients' internal benchmark for 'normal knee' shifts after surgery.
/100
Higher race-day NO2 is linked to slower marathon times, especially in recreational runners, but this is an ecological correlation across only 75 race-days, not proof of a direct causal hit.
/100
In young French children, fitness and physical literacy overlap only partly, so testing one doesn't tell you about the other.
/100
A new name for wearable-data anxiety in athletes, useful language, but the framework and scale behind it are still completely untested.
/100
Adding LET to ACLR cuts graft failure and improves pivot-shift control, but does not meaningfully improve patient-reported outcomes or return to sport.
/100
Football hamstring injuries are mostly non-contact and high-speed, but without exposure data this review can't tell you which actions are actually riskiest.
/100
Adding synovectomy to arthroscopic cuff repair showed no extra pain, motion, strength or satisfaction benefit at 3 months in this 60-patient RCT.
/100
High schoolers show 2.7x the ED basketball-injury rate of college athletes, but the study can't separate 'more injured' from 'more likely to end up in an ED.'
/100
Hip arthroscopy helps dancers with FAI feel and function better and most get back to dance, but of those who returned, under half were still dancing years later, often for reasons that had nothing to do with the hip.
/100
AFT shoes boost running economy by 4% on average, but calf stiffness and navicular drop only explain a quarter of who actually benefits.
/100
Knee OCA grafts fail mostly in the first 3 years (4.9%/yr); clear that window and 10-year survival odds jump to ~90%.
/100
Latarjet patients redislocated less than Bankart patients (3.8% vs 17.6%) at 4+ years, but the two groups weren't well matched at baseline.
/100
Donor age >20y and early graft release (<14 days) were linked to roughly 7x higher OCA failure risk over 8 years; donor BMI and sex-matching made no difference.
/100
MLS Achilles ruptures cost 229 days to return, but the flashy position-specific performance findings rest on single-digit subgroup sizes.
/100
This blood panel is great at confirming concussion but misses about half of true cases, so it can't replace or override the HIA yet.
/100
FEA suggests posterior, non-distal plate placement in MCDFO is mechanically more stable, but it's simulation only, not proven in patients yet.
/100
Elite kayak marathon paddlers sustain 85 to 91% HRmax for over two hours with frequent surges, useful raw material for interval design, but it's one race, not a training trial.
/100
Narrow vs wide-pulse NMES built quadriceps strength equally well in healthy men, but neither improved jump performance, so don't expect NMES alone to boost function.
/100
BFRT gives athletes a modest power boost (SMD ~0.5), useful as a low-load option during rehab or load management, not a replacement for heavy training.
/100
The ACL looks trainable like tendon and bone, but this review is a conceptual framework, not proof any specific training dose cuts injury risk.
/100
IOC's SMHAT2 restructures elite athlete mental health screening into three steps, but this paper doesn't show the numbers proving it screens better than version 1.
/100
A conceptual map of how 'effort' is measured across fields, useful for researchers, not yet actionable for clinicians.
/100
Higher cholesterol tracks with worse heel pain severity, but this snapshot study can't say which causes which, not a reason to check lipids in clinic yet.
/100
A widely-cited PRP mechanism review, not a clinical trial, it explains the biology, not whether PRP actually works for your patient.
/100
Hamstring avulsion repair got everyone back to sport, but only 1 in 3 got back to their old level, and a third had lasting numbness.
/100
Small acute ultrasound study finds knee angle and load affect hamstring fascicle length, but shows no real difference between previously injured and healthy limbs, not ready to guide rehab.
/100
Hallux valgus alters ankle/MTP loading in runners, but 'injury risk' here is simulated, not observed, don't act on it yet.
/100
A small, uncontrolled 9-week Nordic/RDL study in youth Gaelic footballers found modest fascicle-length gains but no strength gains, and was too underpowered to say whether prior hamstring injury blunts adaptation.
/100
A cheap wrist sensor showed a hint of promise for spotting rotator cuff disorders (AUC ~0.7), but n=30 and fair-at-best agreement mean it's nowhere near clinic-ready.
/100
Catastrophic head/neck injuries in non-football sports have fallen roughly 10-fold since the 1980s, but high school gymnasts and hockey players remain the highest-risk group today.
/100
WHO's 2020 update gives clinicians concrete activity dose targets for every population, including pregnancy and chronic disease, but still won't say how much sitting is too much.
/100
Comparing Sway concussion scores to an athlete's own baseline (not just norms) catches more true concussions, but only if you require impairment on 2+ modules, and even then it misses many cases.
/100
ACL patients show different brain activity patterns during movement than controls, but there's still no solid evidence this actually affects how they move.
/100
48 mostly low-quality studies suggest foot/ankle mechanics matter for ACL risk, but with no pooled effect size, it's a hypothesis-generator, not a practice-changer.
/100
Concussion baseline testing predicts risk with just 0.64-0.68 AUC, and that accuracy decays further the longer ago the test was done.
/100
98.5% of elite athletes returned to sport in ~8 weeks after combined ankle ligament and syndesmotic surgery, but with no control group we can't credit the added hardware.
/100
Want the full critical appraisal on every one of these? Become a member →